---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-001533"
form_type: "8-K"
ticker: "CATX"
cik: "0000728387"
company_name: "Perspective Therapeutics, Inc."
filed_at: "2024-01-17T23:59:59+00:00"
generated_at: "2026-06-06T22:50:30.112363+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "medium"
source: SEC EDGAR
---

# Perspective Therapeutics pre-announces ~$9.4M cash; launches stock offering

## Summary
- Preliminary cash and cash equivalents of ~$9.4M as of Dec 31, 2023 (unaudited).
- Sold 1.24M shares at avg $0.303 under ATM program, generating ~$376k gross proceeds.
- Filed preliminary prospectus for proposed common stock offering (size not disclosed).
- Preliminary data subject to change upon completion of audit and year-end procedures.

## SEC filing metadata
- accession: 0001437749-24-001533
- form_type: 8-K
- ticker: CATX
- cik: 0000728387
- company_name: Perspective Therapeutics, Inc.
- filed_at: 2024-01-17T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: medium
- sec_items: 2.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/728387/000143774924001533/0001437749-24-001533-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/728387/000143774924001533/isr20240117_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-001533
- JSON: https://secwatch.observer/filing/0001437749-24-001533.json
- Plain text: https://secwatch.observer/filing/0001437749-24-001533.txt

## Key facts
- Earnings Releases
  Perspective Therapeutics, Inc. reported preliminary financial results for the year ended December 31, 2023.
  - Period: the year ended December 31, 2023
  - Result: preliminary results
  source text: The Preliminary Prospectus Supplement contains certain information and preliminary estimates regarding the Company's financial results for the year ended December 31, 2023, which are set forth below.
  evidence_url: https://www.sec.gov/Archives/edgar/data/728387/000143774924001533/0001437749-24-001533-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.